Navigation Links
Male fertility expert Marvin Meistrich elected AAAS Fellow

HOUSTON - Illuminating the molecular details of normal sperm development, demonstrating how chemotherapy or radiation can leave a man or boy sterile, and pursuing ways to restore fertility have earned a major honor for a scientist at The University of Texas M. D. Anderson Cancer Center.

Marvin Meistrich, Ph.D., professor in M. D. Anderson's Department of Experimental Radiation Oncology, will be inducted as a fellow of the American Association for the Advancement of Science at the association's annual meeting Saturday, Feb. 14, in Chicago.

"Our goal is to find ways to restore the fertility of the thousands of young men and boys every year who receive treatment that might leave them sterile while curing their disease," Meistrich said.

AAAS, founded in 1848, is the world's largest general scientific society. Meistrich is the eighth AAAS fellow on M. D. Anderson's faculty.

"Addressing quality-of-life issues that arise from surviving cancer is an increasingly important aspect of our research. Recognition of Dr. Meistrich's leadership and innovation in this field is richly deserved," said Raymond DuBois, M.D., Ph.D., M. D. Anderson provost and executive vice president and an AAAS fellow since 2004.

Before undergoing treatment now, men can bank their sperm for later in vitro fertilization. Boys have no options for later reproduction. Chemotherapy and radiation destroy stem cells called spermatagonia that differentiate into sperm. If all the stem cells are destroyed, sterility results.

"An important focus of our research is the possibility of banking these sperm stem cells before treatment and then transplanting them later to launch normal sperm production," Meistrich said. This procedure is done now in mice, and Meistrich's plan is to attempt the same in primates.

Normal sperm production begins with the spermatagonia, which either divide into more stem cells or differentiate into cells called spermatocytes then to spermatids and finally sperm, with the male hormone testosterone crucially involved all along.

A major, surprising discovery by Meistrich and colleagues implicates testosterone in the inability of surviving stem cells to restore sperm production after radiation or chemotherapy.

"This was exactly backwards from what we expected to find," Meistrich said. Rat experiments showed that surviving stem cells could not make the next step in sperm development - differentiation into spermatocytes - because of testosterone's effects on the cells that support and nourish the developing sperm cells.

"So we suppressed testosterone until spermatocytes formed, then restored it to complete the process of sperm development," Meistrich said. While this has worked in rodents, translating it to primates has been more complicated, Meistrich said.

"We are trying to understand the molecular mechanism at work in rodents so we can manipulate that mechanism in primates," he said.

Other major contributions from Meistrich's lab include:

  • Development of methods to separate the different cell types in the sequence of sperm development, or spermatogenesis.
  • Demonstration that X- and Y-chromosome sperm can be distinguished from each other through flow cytometry, which led to sorting of these cells.
  • Collaboration with M. D. Anderson clinical faculty to determine which chemotherapeutic and radiation treatments at what doses cause sterility. The resulting information is used in counseling patients about their reproductive options before treatment.
  • Discovery that cancer therapies produce a five-fold increase in chromosome number mutations in sperm formed during treatment. These mutations, which pose a risk of spontaneous abortion or birth defects if conception occurs during or soon after therapy, return to baseline levels months after treatment. Patients are now counseled about this elevated short-term risk and informed that there is no detectable risk if conception occurs 6 months to a year after therapy.


Contact: Scott Merville
University of Texas M. D. Anderson Cancer Center

Related medicine news :

1. Wanted: Pioneer IVF Babies Bay Area Fertility Doctors Launch National Search for First IVF Babies Born 25 Years Ago
2. Special Discounts On Fertility Treatment For Active Duty and Retired Military
3. Fertility Expert Calls Birth of Octuplets Criminal
4. Fertility Focused Acupuncture NW & Associates to Open Clinic in Tacoma
5. Fertility Drugs Do Not Increase Ovarian Cancer Risk
6. Household chemicals may be linked to infertility
7. Local Infertility Specialist, Dr. Rachel Bennett, Westchester Reproductive Medicine, Opens New Office in Mount Kisco
8. The AFAs Infertility Prevention Series Premieres in NYC
9. Free Early Education Program to Lower Infertility Rates
10. Schering-Plough Announces European Submission of Fertility Medicine Corifollitropin Alfa
11. Secondhand smoke raises odds of fertility problems in women
Post Your Comments:
Related Image:
Male fertility expert Marvin Meistrich elected AAAS Fellow
(Date:6/25/2016)... ... 25, 2016 , ... "With 30 hand-drawn hand gesture animations, FCPX users can ... CEO of Pixel Film Studios. , ProHand Cartoon’s package transforms over 1,300 hand-drawn ... X . Simply select a ProHand generator and drag it above media or text ...
(Date:6/25/2016)... Canada (PRWEB) , ... June 25, 2016 , ... Conventional ... pursuit of success. In terms of the latter, setting the bar too high can ... risk more than just slow progress toward their goal. , Research from ...
(Date:6/24/2016)... (PRWEB) , ... June 24, 2016 , ... ... Conference and Scientific Sessions in Dallas that it will receive two significant new ... the grants came as PHA marked its 25th anniversary by recognizing patients, medical ...
(Date:6/24/2016)... (PRWEB) , ... June 24, 2016 , ... People across ... in Genome magazine’s Code Talker Award, an essay contest in which patients and their ... award to be presented at the 2016 National Society of Genetic Counselors (NSGC) Annual ...
(Date:6/24/2016)... ... ... National recruitment firm Slone Partners is pleased to announce the ... as Vice President of North American Capital Sales at HTG Molecular . ... team in the commercialization of the HTG EdgeSeq system and associated reagents in North ...
Breaking Medicine News(10 mins):
(Date:6/23/2016)... 23, 2016 , , , ... 7, 2016 , , , , LOCATION: , , , ... , , , EXPERT PANELISTS:  , , , Frost & Sullivan,s ... Christi Bird; Senior Industry Analyst, Divyaa Ravishankar and Unmesh Lal, Program ... global pharmaceutical industry is witnessing an exceptional era. Several new demand ...
(Date:6/23/2016)...  Guerbet announced today that it has been named ... . One of 12 suppliers to receive ... support of Premier members through exceptional local customer service ... to lower costs. ... outstanding customer service from Premier," says Massimo Carrara ...
(Date:6/23/2016)... -- The Biotechnology industry might still be ... opportunities to investors. assesses the recent performances of ... XON ), Vertex Pharmaceuticals Inc. (NASDAQ: ... ), and Regeneron Pharmaceuticals Inc. (NASDAQ: REGN ... complimentary trade alerts at: ...
Breaking Medicine Technology: